// August 23, 2023
Part One: Industry examining FDA guidance on nitrosamines
Nitrosamine impurities in pharmaceutical products have been making major headlines recently, as t
Nitrosamine impurities in pharmaceutical products have been making major headlines recently, as t
A recently completed pilot project in Vietnam to validate and implement monitoring procedures for
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
Innovation and standardization across borders are essential to facilitate manufacturing solutions